MLchartDataset catalogue

pegylated IL-2 8MW2311

Term · Oncology and biomedicine · MLC-T-ONC-015923

A polyethylene glycol (PEG)-conjugated form of the cytokine interleukin-2 (IL-2), with potential immunopotentiating and antineoplastic activities. Upon administration, pegylated IL-2 8MW2311 activates the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway. This induces the proliferation of CD8+ T cells, enhances tumor cell killing and decreases tumor cell proliferation. Pegylation of IL-2 protects the cytokine from degradation.

Table 1. Record
IdentifierMLC-T-ONC-015923
FieldOncology and biomedicine
Synonymspegylated interleukin-2 8MW2311; PEG-conjugated IL-2 8MW2311
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-015923",
  "term": "pegylated IL-2 8MW2311",
  "field": "Oncology and biomedicine",
  "definition": "A polyethylene glycol (PEG)-conjugated form of the cytokine interleukin-2 (IL-2), with potential immunopotentiating and antineoplastic activities. Upon administration, pegylated IL-2 8MW2311 activates the Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling pathway. This induces the proliferation of CD8+ T cells, enhances tumor cell killing and decreases tumor cell proliferation. Pegylation of IL-2 protects the cytokine from degradation.",
  "synonyms": [
    "pegylated interleukin-2 8MW2311",
    "PEG-conjugated IL-2 8MW2311"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/pegylated-il-2-8mw2311/"
}

Record 12,868 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.